Alzheimer's Drug Discovery Foundation Invites Scientists to Apply for Grant Award Program

NEW YORK, NY--(Marketwire - June 09, 2008) - The Alzheimer's Drug Discovery Foundation (ADDF) invites scientists from the biotechnology industry and academia to apply for a research grant through the Novel Approaches to Drug Discovery for Alzheimer's Disease award program. The goal of the program is to accelerate the discovery, development and clinical evaluation of effective therapies for Alzheimer's disease. This grant award is being made possible through a generous donation from Elan Corporation, plc (NYSE: ELN).